SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase
2024 · Immunity · 119 citations
https://doi.org/10.1016/j.immuni.2024.01.017
D
Daniel Stadlbauer
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
83
Papers
10.0K
Citations
36
h-index
58
i10-index
Daniel Stadlbauer is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Influenza Virus Research Studies & SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies. The author has an h-index of 36, co-authored 71 publications.
ORCID: 0000-0001-6792-7650Papers by this author
worksSafety and immunogenicity of a phase 1/2 randomized clinical trial of a quadrivalent, mRNA-based seasonal influenza vaccine (mRNA-1010) in healthy adults: interim analysis
2023 · Nature Communications · 101 citations
https://doi.org/10.1038/s41467-023-39376-7
Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primates
2024 · Cell · 91 citations
https://doi.org/10.1016/j.cell.2024.08.043
Safety and Immunogenicity of mRNA-1010, an Investigational Seasonal Influenza Vaccine, in Healthy Adults: Final Results From a Phase 1/2 Randomized Trial
2024 · The Journal of Infectious Diseases · 42 citations
https://doi.org/10.1093/infdis/jiae329
Immunologic mechanisms of seasonal influenza vaccination administered by microneedle patch from a randomized phase I trial
2021 · npj Vaccines · 31 citations
https://doi.org/10.1038/s41541-021-00353-0
IgM N-glycosylation correlates with COVID-19 severity and rate of complement deposition
2024 · Nature Communications · 23 citations
https://doi.org/10.1038/s41467-023-44211-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat